Brief: ImmuCell Says Q2 Loss Per Share of $0.09
Aug 12 (Reuters) - ImmuCell Corp ICCC.O :
* IMMUCELL ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR SECOND
QUARTER OF 2019
* Q2 LOSS PER SHARE $0.09
* DURING QUARTER ENDED JUNE 30, 2019, TOTAL PRODUCT SALES
DECREASED BY APPROXIMATELY $305,000 TO $2.7 MILLION
Source text for Eikon: ID:nGNX5XFGdL
Further company coverage: ICCC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ImmuCell
See all newsBrief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results
ImmuCell Q2 revenue rises on higher distributor volume, price realization
Brief: ImmuCell Corporation Q2 EPS USD 0.2
ImmuCell Q2 product sales rise 11.5% on strong US demand
ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year